GLP-1 receptor agonists may lower risks for major illnesses like dementia and seizures.
“However, a recent analysis found that GLP-1s may reduce the risk of dementia, seizures, respiratory illnesses, cardiometabolic disorders, and certain infections more effectively than other diabetes drugs and typical care.”